jnj-38431055
Small moleculeexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2008 (NCT00910923)
Timeline
2000s
- Jan 1, 2008
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
GPR119 agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- jnj-38431055
- jnj-38431055
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01054118 | Phase 1 | Dec 1, 2009 | Johnson and Johnson |
| NCT00946972 | Phase 1 | Jul 1, 2009 | Johnson and Johnson |
| NCT00871507 | Phase 1 | Apr 1, 2009 | Johnson and Johnson |
| NCT00910923 | Phase 1 | Nov 1, 2008 | Johnson and Johnson |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Johnson and Johnson | For profit | 4 | 4 | 1 | 2008 |
1 organizations
Page 1 / 1